BIO’s regime change

After 15 years running biotech’s largest lobbying group, BIO CEO Jim Greenwood will make this election cycle his last.

The former Republican congressman is stepping down at the end of 2020, after which he’ll “help transition a new leader to represent the industry globally and to defend innovation from domestic political attacks,” according to a BIO statement yesterday.

The announcement comes as BIO endures a presidential election in which its industry has been consistently assailed by the incumbent President Trump and each of the most popular Democratic candidates to challenge him come November. It is, as Greenwood noted in a canned quote, “a critical moment for our industry,” which is presumably why he “vowed to keep fighting against short-sighted political attacks in his final 15 months as BIO’s leader.”